|
Sign In to gain access to subscriptions and/or personal tools.
|
Protecting the Heart with Cardiac Medication in Patients with Left Ventricular Dysfunction Undergoing Major Noncardiac Vascular Surgery
Harm H. H. Feringa, MD
Department of Anesthesiology, Erasmus MC, Rotterdam
Jeroen J. Bax, MD, PhD
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
O. Schouten, MD
Department of Vascular Surgery, Erasmus MC, Rotterdam
D. Poldermans, MD, PhD
Department of Cardiology, Erasmus Medical Center, Dr. Molewaterplein 40, Room H-921, 3015 GD Rotterdam, The Netherlands; d.poldermans{at}erasmusmc.nl
Patients with left ventricular dysfunction who are undergoing major noncardiac vascular surgery are at increased risk of adverse postoperative events. We sought to evaluate whether perioperative medication use, including angiotensin-converting enzyme (ACE) inhibitors,b-blockers, statins, and aspirin, was associated with a reduced incidence of postoperative in-hospital mortality in these high-risk patients. The study enrolled 511 patients with left ventricular dysfunction (left ventricular ejection fraction <30%) who were undergoing major noncardiac vascular surgery. Cardiac risk factors and medication use were noted before surgery. Preoperative dobutamine stress echocardiography (DSE) was performed to identify patients with stress-induced myocardial ischemia. The end point was postoperative in-hospital mortality. Univariate and multivariate logistic regression analyses were performed to evaluate the relation between perioperative medication use and mortality. The mean age of the study population was 64 ± 11 years, and 75% were men. Perioperative use of ACE inhibitors, b-blockers, statins, and aspirin was recorded in 215 (48%), 139 (27%), 107 (21%), and 125 patients (24%), respectively. Stress-induced myocardial ischemia occurred in 82 patients (16%). Sixty-four patients (13%) died. Perioperative use of ACE inhibitors (odds ratio [OR], 0.33; 95% confidence interval [CI], 0.12-0.91), b-blockers (OR, 0.03; 95% CI, 0.01-0.26), statins (OR, 0.06; 95% CI, 0.01-0.53), and aspirin (OR, 0.13; 95% CI, 0.03-0.55), was significantly associated with a reduced incidence of mortality, after adjusting for cardiac risk factors and DSE results. In conclusion, the present study showed that the perioperative use of ACE inhibitors,b-blockers, statins, and aspirin is independently associated with a reduced incidence of in-hospital mortality in patients with left ventricular dysfunction who are undergoing major noncardiac vascular surgery.
References
- Davies MK, Hobbs FDR, Davis RC, et al: Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study. Lancet 358:439-444, 2001.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ni H: Prevalence of self-reported heart failure among US adults: Results from the 1999 National Health Interview Survey. Am Heart J 146:121-128, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273:1450-1456, 1995.[Abstract/Free Full Text]
- Foody JM, Farrell MH, Krumholz HM: beta-blocker therapy in heart failure: Scientific review. JAMA 287:883-889,2002.[Abstract/Free Full Text]
- Goldman L, Caldera DL, Nussbaum SR, et al: Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297:845-850, 1977.[Abstract]
- Lee TH, Marcantonio ER, Mangione CM, et al: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043-1049, 1999.[Web of Science][Medline]
[Order article via Infotrieve]
- Kertai MD, Boersma E, Klein J, et al: Optimizing the prediction of perioperative mortality in vascular surgery by using a customized probability model. Arch Intern Med 165:898-904, 2005.[Abstract/Free Full Text]
- Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantification of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367, 1989.[Medline]
[Order article via Infotrieve]
- The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429-1435, 1987.[Abstract]
- The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293-302, 1991.[Abstract]
- The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327:669-677, 1992.[Abstract]
- ACE-Inhibitor Myocardial Infarction Collaborative Group: Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. Lancet 355:1575-1581, 2000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145-153, 2000.[Abstract/Free Full Text]
- Fox KM: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782-788, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hirsch AT, Duprez D: The potential role of angiotensinconverting enzyme inhibition in peripheral arterial disease. Vasc Med 8:273-278, 2003.[Abstract/Free Full Text]
- Vaughan DE: Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease. Eur Heart J 19:G9-G12, 1998.
- Schiffrin EL: Vascular and cardiac benefits of angiotensin receptor blockers. Am J Med 113:409-418, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441-1446, 1993.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- CIBIS Investigators and Committees: A randomized trial of b-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90:1765-1773, 1994.[Medline]
[Order article via Infotrieve]
- CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 353:9-13, 1999.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- MERIT-HF Study Group: Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 283:1295-1302, 2000.[Abstract/Free Full Text]
- Eagle KA, Berger PB, Calkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for non-cardiac surgery—executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257-1267, 2002.[Free Full Text]
- Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789-1794, 1999.[Abstract/Free Full Text]
- The Study of Perioperative Ischemia Research Group: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323:1781-1788, 1990.[Abstract]
- Udelson JE: Ventricular remodeling in heart failure and the effect of beta-blockade. Am J Cardiol 93:B43-B48, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yaeger MP, Fillinger MP, Hettleman BD, et al: Perioperative beta-blockade and late cardiac outcomes: A complementary hypothesis. J Cardiothorac Vasc Anesth 19:237-241, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307, 1995.[Abstract/Free Full Text]
- Cholesterol and Recurrent Events Trial investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001-1009, 1996.[Abstract/Free Full Text]
- The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339:1349-1357, 1998.[Abstract/Free Full Text]
- Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7-22, 2002.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Poldermans D, Bax JJ, Kertai MD, et al: Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107:1848-1851, 2003.[Abstract/Free Full Text]
- Kertai MD, Boersma E, Westerhout CM, et al: Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116:96-103, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Moreno PR, Fuster V: The year in atherothrombosis. J Am Coll Cardiol 44:2099-2110, 2004.[Free Full Text]
- Rauchhaus M, Clark AL, Doehner W, et al: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42:1933-1940, 2003.[Abstract/Free Full Text]
- Antithrombotic Trialists’ Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 324:71-86, 2002.[Abstract/Free Full Text]
Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 10, No. 1,
25-31 (2006)
DOI: 10.1177/108925320601000106
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
American College of Cardiology Foundation, American Heart Association Task Force on Practice, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine, Society for Vascular Surgery, L. A. Fleisher, et al.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
e13 - e118.
[Full Text]
[PDF]
|
|
|
|
|
|
|
2007 WRITING COMMITTEE MEMBERS, L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, et al.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
November 24, 2009;
120(21):
e169 - e276.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, et al.
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)
Eur. Heart J.,
November 2, 2009;
30(22):
2769 - 2812.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. WHINNEY
Perioperative medication management: General principles and practical applications
Cleveland Clinic Journal of Medicine,
November 1, 2009;
76(Suppl_4):
S126 - S132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Hoeks and D. Poldermans
CHAPTER 34 Non-cardiac Surgery in Cardiac Patients
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
e159 - e242.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Circulation,
October 23, 2007;
116(17):
e418 - e500.
[Full Text]
[PDF]
|
|
|
|
|
